Cat.#: ACPP-1653
Despition | CRYM Human Recombinant |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 95%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
ACPP-1373 | Human Interleukin 6 (Active) Protein (AC1373) | 10 µg | inquiry |
ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.